Capillary Technologies India Ltd
Capillary Tech Q2 FY27 Standalone Profit After Tax ₹294.31 million
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 02 Nov 2026, 11:57 AM IST · BSE ID: 812c7bd6-837a-488c-8b41-c2e866d1d9b3
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a standalone profit of ₹294.31 million for the quarter and appointed a new global internal auditor.
🤖 AI Summary
- Capillary Technologies India Limited reported Standalone Profit After Tax of ₹294.31 million for Q2 FY27.
- Standalone Revenue from Operations for the quarter ended 30 September 2026 reached ₹842.58 million.
- The Board approved the appointment of Deloitte Touche Tohmatsu India LLP as the new Internal Auditor.
- Deloitte Touche Tohmatsu India LLP replaces Protiviti India Member Private Limited, effective November 02, 2026.
- The change in internal auditor is to cover the company's expanding scale and international operations.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from operations (Q2 FY27)
₹842.58 million
81.07%
Standalone Profit After Tax (Q2 FY27)
₹294.31 million
Not comparable — prior period loss.
Standalone Basic EPS (Q2 FY27)
₹3.70
Not comparable — prior period loss.
Standalone Revenue from operations (Half-Year FY27)
₹1,485.45 million
67.14%
Standalone Profit After Tax (Half-Year FY27)
₹371.96 million
Not comparable — prior period loss.
🏢 How This Affects the Company
The reported profit and revenue figures indicate ongoing operational activity and revenue generation in core business areas. The appointment of a globally networked internal auditor suggests a focus on scaling international operations and enhancing governance.
The company reported a standalone profit after tax of ₹294.31 million for Q2 FY27, a turnaround from a loss in the prior year comparable period. Revenue from operations increased to ₹842.58 million, contributing to overall income.
The appointment of Deloitte Touche Tohmatsu India LLP as Internal Auditor signifies a strategic move to enhance internal control, risk management, and governance frameworks, particularly for the company's overseas subsidiaries and expanding operations.
Engaging a firm with a global network and specialized expertise for internal audit aims to strengthen the company’s internal control and risk management framework, potentially mitigating operational and financial risks associated with growing international scale.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are indirectly affected by the financial performance reflected in the Q2 FY27 standalone results and the board's decision to enhance internal audit capabilities.
🔍
Management Signal
The appointment of a global audit firm signals management's intent to strengthen internal controls and governance structures in line with the company's expanding operations, including overseas subsidiaries.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q3 FY27 financial results — check revenue and profit growth sustainability.
Updates on the effectiveness of the new internal audit framework.
Any further announcements regarding international operational expansion.
LOW RISK
The filing indicates strong financial performance and governance strengthening initiatives.
💡 Investor Takeaway
Capillary Technologies India Ltd reported standalone Profit After Tax of ₹294.31 million for Q2 FY27, a significant improvement from a ₹(29.65) million loss in Q2 FY26. Standalone Revenue from Operations reached ₹842.58 million for the quarter, up from ₹465.32 million year-over-year. Deloitte Touche Tohmatsu India LLP has been appointed as the new Internal Auditor.
⚖️ Strengths & Concerns
✅ Positives
- Standalone Profit After Tax for Q2 FY27 was ₹294.31 million, a positive shift from a loss of ₹(29.65) million in Q2 FY26.
- Standalone Revenue from Operations for Q2 FY27 increased to ₹842.58 million from ₹465.32 million in Q2 FY26.
⚠️ Concerns
- Professional and consultancy expenses increased to ₹56.34 million in Q2 FY27 from ₹55.04 million in Q2 FY26.
- Employee benefit expense rose to ₹324.49 million in Q2 FY27 from ₹280.68 million in Q2 FY26.
📅 Company Track Record
Capillary Technologies has demonstrated growth in recent periods. In Q1 FY27, Operating Revenue grew 43% YoY to ₹2,566.4 Mn with a standalone profit after tax of ₹77.65 million, up from a ₹(51.21) million loss YoY. Q2 FY27 continues this trend with a 51% YoY operating revenue growth to ₹2,713.5 Mn (consolidated, from press release) and significant profit turnaround.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Capillary Technologies India Ltd's standalone profit after tax in Q2 FY27?
Capillary Technologies India Ltd reported a standalone Profit After Tax of ₹294.31 million for the quarter ended 30 September 2026 (Q2 FY27).
What was Capillary Technologies India Ltd's standalone revenue from operations in Q2 FY27?
The standalone Revenue from Operations for Capillary Technologies India Ltd in Q2 FY27 was ₹842.58 million.
Who has been appointed as the new Internal Auditor for Capillary Technologies India Ltd?
M/s. Deloitte Touche Tohmatsu India LLP has been appointed as the new Internal Auditor for Capillary Technologies India Ltd, effective November 02, 2026.
What is the reason for the change in Capillary Technologies India Ltd's internal auditor?
The change is to engage a firm with a global network and specialized expertise to cover the expanding scale and international operations, and to strengthen the internal control, risk management, and governance framework of Capillary Technologies India Ltd.
Questions based on this BSE filing only. For information purposes.